This brief provides a description of the Cascade Analysis Tool (CAT) and a summary of an early application of the tool in Poltava Region, central Ukraine. The CAT is a mathematical model with a generic...
Medical devices, ranging from a simple disposable syringe to a high end PET/CT scanner, pose significant regulatory, planning and management challenges for client countries. Michael Cheng provides a practical...
In virtually every country in the world, governments, social security fund managers and health insurers are struggling with ever increasing drug bills. This note explains cost drivers, provides insights...
Many health projects rely on a regular supply of quality pharmaceuticals. Here is a practical guide how to assure drug quality along the distribution chain and win the fight against substandard and counterfeit...
Privatization in the tobacco industry should follow general good practice: a sound regulatory environment will yield economic and health benefits. This note provides clear guidelines and information on...
Regulation of pharmaceuticals is a complex task. Andreas Seiter's note reviews the role of drug regulatory authorities in developing countries and discusses how to set priorities in line with the overall...
What factors must be weighed when deciding whether to promote local manufacturing of pharmaceuticals in developing countries? Andreas Seiter's note summarizes pros, cons and key issues. Pharmaceuticals...
Counterfeit and substandard drugs jeopardize health and waste money. Andreas Seiter reviews dimensions of the problem and contributing factors, and how countries can ensure drug quality. Pharmaceutical...
In Africa many Poverty Reduction Strategy Paper (PRSPs) include immunization coverage targets, and debt relief often provides additional funds to help achieve them. Joe Naimoli looks at some implications...